These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 28982366

  • 1. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
    Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A.
    Mol Cancer; 2017 Oct 05; 16(1):156. PubMed ID: 28982366
    [Abstract] [Full Text] [Related]

  • 2. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB.
    BMC Cancer; 2019 Feb 08; 19(1):129. PubMed ID: 30736753
    [Abstract] [Full Text] [Related]

  • 3. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A.
    Prostate; 2016 Jan 08; 76(1):68-79. PubMed ID: 26417675
    [Abstract] [Full Text] [Related]

  • 4. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ.
    Prostate; 2019 Jan 08; 79(1):88-95. PubMed ID: 30194772
    [Abstract] [Full Text] [Related]

  • 5. Urinary exosomal microRNA profiling in intermediate-risk prostate cancer.
    Kim MY, Shin H, Moon HW, Park YH, Park J, Lee JY.
    Sci Rep; 2021 Apr 01; 11(1):7355. PubMed ID: 33795765
    [Abstract] [Full Text] [Related]

  • 6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 01; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 7. Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer.
    Yu Q, Li P, Weng M, Wu S, Zhang Y, Chen X, Zhang Q, Shen G, Ding X, Fu S.
    J Biomed Nanotechnol; 2018 Jan 01; 14(1):168-178. PubMed ID: 29463374
    [Abstract] [Full Text] [Related]

  • 8. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z.
    Int J Mol Sci; 2017 Jun 16; 18(6):. PubMed ID: 28621736
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C.
    Clin Cancer Res; 2017 Sep 01; 23(17):5311-5319. PubMed ID: 28606918
    [Abstract] [Full Text] [Related]

  • 10. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC.
    Oncotarget; 2016 Jan 26; 7(4):3993-4008. PubMed ID: 26675257
    [Abstract] [Full Text] [Related]

  • 11. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.
    Chen T, Wang C, Yu H, Ding M, Zhang C, Lu X, Zhang CY, Zhang C.
    EBioMedicine; 2019 Jan 26; 39():552-561. PubMed ID: 30467011
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ.
    J Clin Lab Anal; 2018 Feb 26; 32(2):. PubMed ID: 28383146
    [Abstract] [Full Text] [Related]

  • 13. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ.
    Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715
    [Abstract] [Full Text] [Related]

  • 14. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, Beadnall H, Barnett MH, Suter CM, Buckland ME.
    Sci Rep; 2017 Oct 30; 7(1):14293. PubMed ID: 29084979
    [Abstract] [Full Text] [Related]

  • 15. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L.
    Prostate; 2017 Jul 30; 77(10):1167-1175. PubMed ID: 28617988
    [Abstract] [Full Text] [Related]

  • 16. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Ramirez-Garrastacho M, Berge V, Linē A, Llorente A.
    Br J Cancer; 2022 Feb 30; 126(3):492-501. PubMed ID: 34811506
    [Abstract] [Full Text] [Related]

  • 17. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Fredsøe J, Rasmussen AKI, Mouritzen P, Borre M, Ørntoft T, Sørensen KD.
    Int J Cancer; 2019 Nov 01; 145(9):2558-2567. PubMed ID: 30903800
    [Abstract] [Full Text] [Related]

  • 18. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.
    PLoS One; 2015 Nov 01; 10(10):e0139233. PubMed ID: 26426747
    [Abstract] [Full Text] [Related]

  • 19. Urinary biomarkers of prostate cancer.
    Fujita K, Nonomura N.
    Int J Urol; 2018 Sep 01; 25(9):770-779. PubMed ID: 30129068
    [Abstract] [Full Text] [Related]

  • 20. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H, Shi X, Li H, Hui J, Liu R, Chen Z, Lu Y, Tan W.
    BMC Cancer; 2021 Dec 03; 21(1):1293. PubMed ID: 34861847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.